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Impact of body mass index on 
robotic transaxillary thyroidectomy
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obesity is associated with increased operating times and higher complication rates in many types 
of surgery. Its impact on robotic thyroidectomy however, is not well documented. the aim of this 
study was to investigate the relationship between body mass index (BMI) and robotic transaxillary 
thyroidectomy (RtAt). A retrospective review of prospectively collected data of all patients who 
underwent RTAT at Yonsei University Health System from October 2007 to December 2014 was 
performed. Patients were divided into three groups based on BMI (Group 1: BMI < 25, Group 2: BMI 
25–29.99, Group 3: BMI ≥ 30), and compared. A total of 3697 patients were analyzed. No differences 
between the three groups were observed in clinicopathological factors, extent of surgery or length of 
stay. After multivariate analysis, only seroma and transient voice hoarseness were related to increasing 
BMI. Total operative time was significantly longer for Group 3 patients with less-than-bilateral total 
thyroidectomy (BTT), but was not significantly different for patients with BTT. Although obese patients 
undergoing RtAt have a slightly higher risk of seroma, transient voice hoarseness, and longer operative 
times, BMI did not influence the other important surgical outcomes of thyroidectomy. Therefore, 
obesity should not be a contraindication for performing RtAt.
Minimally invasive surgery (MIS) is an increasingly common technique used in most surgical practices because 
of advantages of smaller incisions, reduced pain, less blood loss, shorter length of hospital stay, and earlier return 
to work. MIS for cervical endocrine glands began in 1996 when Gagner performed the first endoscopic sub-
total parathyroidectomy in a patient with primary hyperparathyroidism1. Subsequently in 1997, Huscher et 
al. described the first endoscopic right thyroid lobectomy2. Different endoscopic approaches have since been 
developed and performed worldwide for better cosmesis and avoidance of neck scars. Endoscopic techniques 
are however limited by rigid instruments that cannot articulate for more precise retraction and dissection of vital 
structures around the thyroid gland.
Our institution developed gasless, robotic transaxillary thyroidectomy (RTAT) in 20073. Since then, we have 
performed more than 5000 thyroidectomies using this technique, achieving results that are comparable in com-
plication rates and oncological outcomes to standard open operation4. Some surgeons have, however, been skep-
tical that such good results are only possible because of favorable patient body habitus, as the Korean population 
is mostly within the normal BMI range, as opposed to patients from Western countries where the obesity rate 
is much higher. This difference was highlighted in the 2013–2014 National Health and Nutrition Examination 
Survey that reported a U.S. obesity rate (BMI ≥ 30 kg/m2) of 40.4% in females and 35.0% in males5. The obesity 
rate in South Korea as reported by the Korean National Health and Nutrition Examination Survey for the same 
period, was 4.3% for females and 5.3% for males6.
Despite the significantly lower obesity rate in South Korea, our department still manages a small number of 
obese patients. Given that few objective data are available on the relationship between obesity and surgical out-
comes of patients undergoing RTAT, we, at the largest robotic thyroidectomy center in the world, investigated the 
impact of BMI on operative time, morbidity and long-term outcomes of RTAT at our institution.
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Materials and Methods
patients. A retrospective review of our database containing prospectively collected data of all patients who 
underwent RTAT at Yonsei University Health System, Seoul, Korea from October 2007 to December 2014 was 
performed. Patients who had undergone simultaneous lateral neck dissection, completion total thyroidectomy 
or re-operation were excluded. Patients were divided into three groups based on World Health Organization 
classification7: BMI < 25 kg/m2 (normal or underweight, Group 1), BMI 25–29.99 kg/m2 (overweight, Group 2) 
and BMI ≥ 30 kg/m2 (obese, Group 3). The minimum follow-up period was 30 months. This study was approved 
by the Institutional Review Board (IRB) of Yonsei University College of Medicine (IRB number 4–2018–0375). 
Individual patient consent was waived because of the retrospective nature of the study and no patient identifying 
information was used.
surgery. Operations were subdivided into three components: creation of working space (flap dissection), 
docking (docking of robotic arms), and console times (time to perform thyroidectomy). Operations were defined 
as BTT, or less-than-BTT if ipsilateral lobectomy was performed with or without partial contralateral thyroidec-
tomy. We routinely performed prophylactic central compartment neck dissection (CCND) for malignant cases. 
All surgeries were performed by consultant surgeons or training fellows in our hospital.
Clinicopathological factors. Patients’ clinicopathological factors including age, sex, tumor size, multifo-
cality, bilaterality, extra-capsular invasion, mean number of central nodes harvested, and central node positivity 
were recorded and compared. Operative times, complications, and recurrences were also analyzed.
statistical analysis. Continuous variables are reported as mean ± standard deviation, and comparisons 
between groups were performed using Student’s t-test. Categorical data are recorded as numbers with percentage 
and analyzed with Pearson χ2 test or Fisher’s exact tests. Associations between surgical outcomes and operative 
times and clinicopathological factors including BMI were assessed using logistic regression and multiple linear 
regression. Statistical significance was set at p < 0.05. All statistical analyses were performed using SPSS software 
version 23.0 (IBM Corp., Armonk, NY).
Results
Clinicopathological factors. A total of 3697 patients were included. Group 1 consisted of 3062 patients, 
Group 2 had 559 and Group 3 had 76 patients. The mean age of the entire cohort was 38.7 ± 9.2 years, the per-
centage of females was 89.3% and the percentage of males was 10.7%. The number and mean BMI of obese 
patients were randomly distributed across the study period (Figs 1 and 2). Mean tumor size was 0.79 ± 0.59 cm, 
and malignancy rate was 96.2%. Multifocal tumors were found in 22.2% of our patients, and 11.3% of tumors 
were bilateral. Extracapsular invasion was present in 43.5% of patients. There was no significant difference in the 
distribution of patients across the three groups according to the TNM staging for malignant patients (Table 1). 
Most of the cancers were T1 cancers measuring less ≤ 2 cm in size (55.0%), whilst 1% were T2 cancers (2–4 cm). 
43.8% of the cases were T3 cancers with minimal extrathyroidal tumor extension, according to the 7th Edition 
of the TNM Classification System for Differentiated Thyroid Carcinoma8. The mean number of central nodes 
removed was 4.60 ± 3.85, and the mean number of positive nodes was 0.74 ± 1.58. Mean post-operative inpatient 
stay was 3.23 ± 1.6 days, and recurrence rate was 0.6%. Comparisons among the three groups found no significant 
differences apart from age, sex, and tumor multifocality (Table 1). Multifocality was no longer significant after 
multivariate analysis. Recurrence rates were also similar across the three groups, at 0.6% for the entire cohort.
Complications. Major complications associated with thyroidectomy are shown in Table 2. The overall 
recurrent laryngeal nerve injury rate was 0.4%, hematoma requiring surgical intervention 0.1%, and transient 
Figure 1. Number of obese patients treated over time.
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hypocalcaemia rate of 37.4% (in BTT group). No significant difference was seen in complication rates between 
the three BMI groups except for seroma formation and transient voice hoarseness. After multivariate analysis, 
transient voice hoarseness was significantly associated with Group 3 patients (OR 3.06; p = 0.02), bilateral total 
thyroidectomy (OR 1.87; p = 0.02) and longer console time (OR 1.02; p < 0.001). The risk of seroma was higher in 
both the overweight and obese groups (Group 2 OR 4.59; p value < 0.001, Group 3 OR 7.24; p < 0.001) (Table 3).
operative times. Univariate analysis showed significant differences in operative time between the three BMI 
groups. The mean total operative time for Group 3 patients was 136.59 minutes compared to 115.20 minutes for 
Group 1, and 118.11 minutes for Group 2 patients with less-than-BTT (p = 0.001). Most time was spent creating 
the working space (Group 3, 45.36 minutes; Group 2, 38.13 minutes; Group 1, 36.71 minutes; p = 0.001), followed 
by console time (Group 3, 50.09 minutes; Group 2, 43.56 minutes; Group 1, 42.53 minutes; p = 0.018). Docking 
time was similar for all patients. For BTT, only working space time was significantly different across the three 
groups (p = 0.02).
Multivariate analysis using multiple linear regression confirmed a positive relationship between BMI and 
operative time, with longer creation of working space time required for every increasing unit of BMI ≥ 30 
(less-than-BTT, β coefficient 8.66; p < 0.001; BTT, β coefficient 5.16; p = 0.038). The positive relationship with 
BMI was also evident for total operative time. Other factors that were independently related to longer operative 
times were tumor size, number of central nodes removed and male sex. Details of the univariate and multivariate 
analyses of factors associated with operative times are highlighted in Tables 4 and 5.
Discussion
Remote access thyroidectomy is becoming increasingly popular because of its superior cosmetic outcomes, which 
may be an important consideration, especially for young female patients. This technique, however, is less pop-
ular in Western countries, perhaps because of complications such as brachial plexus palsy and bleeding that 
were reported by some centers during their initial learning curve9,10. Nonetheless, evidence from North America 
indicates that RTAT is safe and feasible in a Western population9–11. Another factor that often influences patient 
selection for this procedure in centers that are not experienced in RTAT is patient BMI, with frequent concerns 
that higher BMI is associated with higher risk of morbidity.
Although high BMI is associated with higher risk of post-operative complications for many types of sur-
gery12–15, it is not necessarily linked to higher risk for thyroidectomy patients. Milone et al.16 reported no signifi-
cant difference in post-operative complications or length of stay following open thyroidectomy for patients with 
BMI < 25 kg/m2 or BMI ≥ 25 kg/m2 (N = 266). Overweight and obese patients however, required longer operative 
times. In contrast, a retrospective review of 26,864 patients who underwent thyroidectomy and parathyroidec-
tomy by Buerba et al.17 found that morbidly obese patients had more urinary complications, and obese and mor-
bidly obese patients were more likely to have wound complications. These patients also had longer surgical times. 
The limitation of that study, however, was that only general surgical complications such as wound, urinary, and 
cardiovascular and pulmonary complications were examined. The study did not investigate thyroid-specific and 
parathyroid-specific complications such as recurrent laryngeal nerve (RLN) injury and hypocalcemia.
Our study examined thyroid-specific complications and, to our knowledge, the largest number of robotic 
thyroidectomy patients (N = 3697) grouped according to BMI. Similar to results for open thyroidectomy from 
Milone et al., our study found no difference in complication rates when comparing patients with different BMIs, 
apart from transient voice hoarseness in the obese group and seroma formation. The most likely reason for the 
higher rate of transient voice hoarseness in obese patients was that they tended to have more adipose tissue in the 
paratracheal area and deeper RLN location. These factors made identifying the nerve more difficult, leading to 
possible traction injury.
Figure 2. Mean BMI of obese patients according to year of surgery.
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Seroma formation is difficult to avoid in overweight or obese patients. As reported in our previous publi-
cations3,18, creation of working space involves dissection of soft tissue anterior to the pectoralis major muscle 
and lifting of the platysma in the posterior neck and over the sternocleidomastoid (SCM) muscle. The SCM is 
then split between its two bellies to access the central neck area. Strap muscles are then dissected to expose the 
thyroid gland. In obese patients, the surface area that is dissected during this part of the operation is larger than 
in non-obese patients, and exposure of a large amount of adipose tissue increases the risk of seroma formation.
Other common complications associated with thyroidectomy such as RLN injury, hematoma and transient 
hypocalcemia were similar among all patients regardless of BMI. The complication rates were similar to those 
associated with open surgery, as we published previously19. Although we found a significant difference in rates of 
skin burn/infections, the sample was too small to show clinical significance. Other rarer complications such as 
tracheal injury, Horner’s syndrome and brachial plexus traction injury occurred only in the normal-weight group.
Similar to other publications9,16,17, our study showed that operative time is positively related to patient BMI. 
The longer operative time was most noticeable in time required for creation of working space (flap dissection). 
In the transaxillary approach, the most critical step in flap dissection is dissection of the subplatysma plane in 
the posterior neck. In obese patients, recognition of the platysma muscle is difficult and time consuming because 
Total cohort
Group 1 
(BMI < 25 kg/m2)
Group 2 (BMI 
25–29.99 kg/m2)
Group 3 
(BMI ≥ 30 kg/m2) p value
Number of patients 3697 (100%) 3062 (82.8%) 559 (15.1%) 76 (2.1%)
Age (years) 38.7 ± 9.2 38.2 ± 9.0 41.5 ± 9.2 38.2 ± 10.1 <0.001*
Gender 0.001*
 Female 3303 (89.3%) 2825 (92.3%) 422 (75.5%) 56 (73.7%)
 Male 394 (10.7%) 237 (7.7%) 137 (24.5%) 20 (26.3%)
Mean BMI 22.2 ± 3.1 21.2 ± 2.0 26.7 ± 1.3 32.4 ± 2.4 0.001*
Mean tumor size (cm) 0.79 ± 0.59 0.78 ± 0.59 0.81 ± 0.60 0.85 ± 0.78 0.498
Malignancy 3555 (96.2%) 2943 (96.1%) 538 (96.2%) 74 (97.4%) 0.848
§TNM staging
T
1 1954 (55.0%) 1620 (55.0%) 291 (54.1%) 43 (58.1%) 0.749
2 36 (1.0%) 33 (1.12%) 2 (0.37%) 1 (1.36%)
3 1558 (43.8%) 1284 (43.6%) 244 (45.4%) 30 (40.5%)
4 7 (0.2%) 6 (0.20%) 1 (0.19%) 0 (0.0%)
N
0 2451 (68.9%) 2042 (69.4%) 367 (68.2%) 42 (56.8%) 0.187
1a 1094 (30.8%) 892 (30.3%) 170 (31.6%) 32 (43.3%)
1b 10 (0.3%) 9 (0.31%) 1 (0.19%) 0 (0.0%)
M
0 3555 (100%) 2943 (100%) 538 (100%) 74 (100%)
1 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Stage
I 3036 (85.4%) 2559 (86.9%) 415 (77.1%) 62 (83.8%)
II 4 (0.11%) 3 (0.1%) 1 (0.2%) 0 (0.0%)
III 511 (14.4%) 378 (12.9%) 121 (22.5%) 12 (16.2%)
IVa 4 (0.13%) 3 (0.1%) 1 (0.2%) 0 (0.0%)
IVb 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
#Multifocal tumor 0.006*
No 2825 (77.6%) 2368 (78.5%) 409 (74.5%) 48 (64.0%)
Yes 808 (22.2%) 641 (21.3%) 140 (25.5%) 27 (36.0%)
#Bilateral tumor 0.359
No 3246 (88.7%) 2698 (89.1%) 482 (87.0%) 66 (88.0%)
Yes 412 (11.3%) 331 (10.9%) 72 (13.0%) 9 (12.0%)
#Extracapsular invasion 0.854
No 2023 (56.4%) 1680 (56.5%) 299 (55.1%) 44 (59.5%)
Yes 1563 (43.5%) 1289 (43.4%) 244 (44.9%) 30 (40.5%)
Extent of surgery 0.199
Less than BTT 2377 (64.3%) 1987 (64.9%) 346 (61.9%) 44 (57.9%)
BTT 1320 (35.7%) 1075 (35.1%) 213 (38.1%) 32 (42.1%)
Mean no. of central nodes removed 4.60 ± 3.85 4.60 ± 3.89 4.52 ± 3.61 5.30 ± 3.96 0.262
Mean no. of positive central node 0.74 ± 1.58 0.73 ± 1.58 0.79 ± 1.60 1.03 ± 1.59 0.208
Post-operative inpatient stay (days) 3.23 ± 1.6 3.22 ± 1.7 3.27 ± 0.9 3.23 ± 1.6 0.674
Recurrence 22 (0.6%) 20 (0.7%) 2 (0.4%) 0 (0.0%) 0.559
Table 1. Patient demographics and clinicopathological factors. BMI, body mass index; BTT, bilateral total 
thyroidectomy; §AJCC 7th Edition/TNM Classification System for Differentiated Thyroid Carcinoma; #Data not 
available for the entire cohort; *statistically significant at p < 0.05.
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of excessive fatty tissue in that area. In addition, a thick subcutaneous flap hinders the view of the surgical field 
after the endoscope is docked. Hence, a larger flap is required compared to non-obese patients, resulting in longer 
operating time. Excess adipose tissue in the central compartment area also makes identifying the RLN and dis-
section of the central compartment nodes more difficult, leading to longer console times in obese patients. Fatty 
tissues are also more likely to bleed and require more meticulous hemostasis and longer operative time.
Total cohort 
(N = 3697)
Group 1 
(BMI < 25) 
(N = 3062)
Group 
2 (BMI 
25–29.99) 
(N = 559)
Group 3 
(BMI ≥ 30) 
(N = 76) p value
RLN injury 14 (0.4%) 12 (0.4%) 2 (0.4%) 0 (0.0%) 0.857
Transient voice hoarseness 88 (2.4%) 69 (2.3%) 14 (2.5%) 5 (6.6%) 0.049*
#Transient hypocalcemia 494 (37.4%) 414 (38.5%) 69 (32.4%) 11 (34.4%) 0.226
Seroma 55 (1.5%) 28 (0.9%) 23 (4.1%) 4 (5.3%) 0.001*
Hematoma (observation) 10 (0.3%) 9 (0.3%) 1 (0.2%) 0 (0.0%) 0.802
Hematoma (surgery) 3 (0.1%) 2 (0.1%) 1 (0.2%) 0 (0.0%) 0.665
Chyle leak 14 (0.4%) 13 (0.4%) 1 (0.2%) 0 (0.0%) 0.591
Tracheal injury 7 (0.2%) 7 (0.2%) 0 (0.0%) 0 (0.0%) 0.483
Horner’s syndrome 1 (0.03%) 1 (0.03%) 0 (0.0%) 0 (0.0%) 0.901
Brachial plexus traction 
injury 4 (0.1%) 4 (0.1%) 0 (0.0%) 0 (0.0%) 0.660
Wound burn or infection 8 (0.2%) 4 (0.1%) 3 (0.5%) 1 (1.3%) 0.019*
Table 2. Complication rates for the three BMI groups. BMI, body mass index in kg/m2; RLN, recurrent 
laryngeal nerve; #Bilateral total thyroidectomy patients only (N = 1320); *statistically significant at p < 0.05.
Complications
Odds 
ratio
95% confidence 
interval p value
Transient voice hoarseness
 BTT 1.87 1.10–3.18 0.020*
 Number of retrieved 
CLNs 0.99 0.93–1.05 0.677
 Male sex 0.50 0.21–1.18 0.114
 Console time 1.02 1.00–1.03 <0.001*
 BMI 25–29.99 kg/m2 1.15 0.64–2.08 0.645
 BMI ≥ 30 kg/m2 3.06 1.17–7.98 0.023*
#Transient hypocalcaemia
 Male sex 0.59 0.39–0.90 0.013*
 Number of retrieved 
CLNs 1.03 0.99–1.06 0.059
 Tumor size (cm) 0.91 0.74–1.12 0.392
 BMI 25–29.99 kg/m2 0.80 0.58–1.11 0.187
 BMI ≥ 30 kg/m2 0.91 0.43–1.94 0.813
Seroma
 Male sex 0.46 0.16–1.31 0.145
 Number of retrieved 
CLNs 0.95 0.87–1.03 0.237
 Tumor size 0.84 0.41–1.69 0.616
 BMI 25–29.99 kg/m2 4.59 2.52–8.37 <0.001*
 BMI ≥ 30 kg/m2 7.24 2.42–21.64 <0.001*
Recurrent laryngeal nerve injury
 Male sex 1.66 0.34–8.22 0.534
 Number of retrieved 
CLNs 0.92 0.76–1.10 0.348
 Tumor size 1.05 0.33–3.35 0.941
 BMI 25–29.99 kg/m2 0.93 0.19–4.49 0.931
 BMI ≥ 30 kg/m2 0 (no event)
Table 3. Multivariate analysis of risk factors associated with common thyroidectomy complications BMI, 
body mass index; BTT, bilateral total thyroidectomy; CLN, central lymph node; #Bilateral total thyroidectomy 
patients only; *statistically significant at p < 0.05.
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Total cohort
Group 1 
(BMI < 25)
Group 2 (BMI 
25–29.99)
Group 3 
(BMI ≥ 30) p value
Less-than-BTT
 Total time 116.02 ± 29.54 115.20 ± 28.94 118.11 ± 28.56 136.59 ± 49.82 0.001*
 Working space time 36.71 ± 14.11 36.27 ± 13.92 38.13 ± 14.63 45.36 ± 14.88 0.001*
 Docking time 4.86 ± 2.64 4.88 ± 2.57 4.78 ± 3.11 4.73 ± 1.52 0.751
 Console time 42.83 ± 18.26 42.53 ± 17.88 43.56 ± 19.07 50.09 ± 25.76 0.018*
BTT
 Total time 142.22 ± 31.52 141.39 ± 32.20 145.99 ± 28.07 145.09 ± 28.85 0.134
 Working space time 38.41 ± 13.95 38.00 ± 13.57 39.62 ± 15.21 44.16 ± 16.64 0.020*
 Docking time 4.67 ± 2.08 4.70 ± 2.14 4.52 ± 1.84 4.58 ± 1.52 0.501
 Console time 62.74 ± 21.43 62.15 ± 21.40 65.37 ± 21.36 64.94 ± 22.05 0.117
Table 4. Operative times across the three BMI groups. All times in minutes; BMI, body mass index in kg/m2; 
BTT, bilateral total thyroidectomy; *statistically significant at p < 0.05.
Operation Associated factors
Beta 
coefficient
95% 
confidence 
interval p value
Working space 
time Less-than-BTT Sex (male) 3.97 2.10–5.85 <0.001*
BMI
25–29.99 1.24 −0.40–2.87 0.138
≥30 8.66 4.49–12.83 <0.001*
BTT Tumor size (cm) 1.39 0.09–2.69 0.036*
Sex (male) 4.98 2.49–7.47 <0.001*
BMI
25–29.99 1.05 −1.03–3.12 0.324
≥30 5.16 0.29–10.03 0.038*
Console time Less-than-BTT Number of CLNs retrieved 0.34 0.12–0.56 0.003*
BMI
25–29.99 −0.30 −2.48–1.88 0.786
≥30 5.12 −0.45–10.70 0.072
BTT Tumor size (cm) 2.28 0.25–4.30 0.028*
Number of CLNs 
retrieved 0.53 0.24–0.83 <0.001*
Sex (male) 8.55 4.69 12.41 <0.001*
BMI
25–29.99 2.76 −0.47–5.99 0.094
≥30 0.34 −7.12–7.80 0.928
Total operating 
time Less-than-BTT Tumor size (cm) 5.54 2.00–9.09 0.002*
Extracapsular invasion 2.57 0.02–5.13 0.048*
Sex (male) 5.94 1.95–9.94 0.004*
BMI
25–29.99 0.12 −3.37–3.61 0.946
≥30 18.54 9.63–27.46 <0.001*
BTT Tumor size (cm) 4.18 1.29–7.08 0.005*
Number of CLNs 
retrieved 0.53 0.11–0.95 0.013*
Sex (male) 20.67 15.13–26.21 <0.001*
BMI
25–29.99 2.33 −2.28–6.93 0.32
≥30 −2.15 −12.83–8.53 0.69
Table 5. Factors associated with operating time in multivariate analysis All times in minutes; BMI, body 
mass index, in kg/m2; BTT, bilateral total thyroidectomy; CLN, central lymph node; *statistically significant at 
p < 0.05.
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The total operative time for BTT compared to the less-than-BTT group was not significantly increased in the 
higher BMI groups. The reason for this finding could be because our institution is a teaching hospital, and flap 
raising and hemithyroidectomies were mostly performed by training fellows. The speed at which they performed 
these procedures varied according to their level of training. Contralateral lobectomies in BTT cases were often 
performed by our experienced consultant surgeons, who were able to perform this part of the surgery proficiently, 
regardless of patient BMI.
Our result is similar to results from Lee et al.20, who compared 310 women who underwent bilateral 
axillo-breast approach robotic thyroidectomy for papillary thyroid carcinoma. Lee et al. found no difference in 
post-operative complications, operative times, number of retrieved central lymph nodes (CLNs), or length of 
hospital stay when comparing patients with BMI < 25 kg/m2 and BMI ≥ 25 kg/m2. Our study was however more 
representative of a general population with inclusion of men in the cohort. We also stratified our patients into 
three rather than two BMI groups.
Our result is also comparable with studies from Western countries, where more overweight and obese patients 
were treated. The case series by Kandil et al.9 from the United States described an overweight and obese popu-
lation of 23% and 37% respectively. Their overall BMI was 28.5 kg/m2. They found no significant difference in 
complications between obese and normal weight patients. Another more recently published article by Russell 
et al.21 investigated all remote access thyroidectomy in a North American population, including the transaxil-
lary approach. Their mean BMI was 27.5 kg/m2. They were able to successfully perform thyroidectomies using 
the transaxillary and transoral approaches in patients with BMI > 40 kg/m2 without complications. There was 
however no breakdown of the data comparing the different remote access surgeries. Nevertheless, their data 
also demonstrated that robotic transaxillary thyroidectomy is feasible in an obese population without increased 
morbidity.
Another significant result from our multivariate analysis was that longer operative time was required for male 
patients, larger tumor size, and number of CLNs retrieved during CCND. Flap dissection was generally more 
time consuming in males due to less supple tissue, longer shoulder lengths and larger muscles, making muscle 
retraction more difficult. Having larger larynx and trachea also made contralateral lobectomy more challenging, 
as evident from the longer console time for BTT in males (β coefficient 8.55, p < 0.001). The operations were more 
challenging because of difficulty retracting the trachea to expose the contralateral lobe. Sex was not significantly 
related to console time in the group with less-than-BTT.
The risk of transient voice hoarseness was higher in patients who underwent BTT and those who had longer 
console times (BTT OR 1.87, p = 0.02; console time OR 1.02, p < 0.001). Being male was related to lower risk of 
hypocalcemia (OR 0.59, p = 0.013), but the reason for this was not apparent.
Looking at thyroidectomy in general, larger and more advanced thyroid carcinomas are assumed to be asso-
ciated with higher risk of complications. During the early phase of the learning curve as published by our insti-
tution and others3,22,23, only patients with tumors ≤ 2 cm were offered RTAT. But as the surgeons became more 
experienced, tumor size was no longer a limiting factor for performing RTAT. According to our data, tumor size 
was not a significant risk factor for complications, even after multivariate analysis (Table 3). We acknowledge that 
our data was potentially limited by small tumors, (mean tumor size 0.79 cm) and only 79 patients had tumors 
greater than 2 cm. Four of the patients had tumors up to 6 cm, and two patients had tumors measuring up to 7 cm. 
The data on thyroid volumes was unfortunately not available as this was not recorded in our database.
Many surgeons are concerned about the feasibility RTAT when cancers extended into the trachea or RLN 
(T4a tumors). Our institution does not offer RTAT to patients with known T4 tumors diagnosed on pre-operative 
imaging or clinically. However, if the tumor was found to invade the trachea or RLN during the operation, the 
tumor would be shaved off these structures. Tumor involvement is usually minimal in these settings. According 
to our data, there were seven cases of T4a tumors (Table 1). All of them had their tumors shaved from the trachea 
or RLN with robotic scissors and had adjuvant radioactive iodine treatment. No recurrences were detected in any 
of these patients up to today.
Involvement of central and lateral neck nodes are not contraindications to having RTAT because we have 
excellent views of the central and lateral neck areas and are able to perform very comprehensive neck dissections 
using this technique. Equivalent outcome between traditional open and robotic transaxillary lateral neck dissec-
tion have previously been published by our institution19.
As with any new technique, the relationship between the learning curve and complication rate is important. 
We previously analyzed the learning curve associated with RTAT, and compared the robotic technique with open 
surgery. We found no differences in outcome between the two approaches. Complication rates were also not 
statistically different between the first, second and third thousand patients grouped chronologically according 
to year of surgery. The absolute number of complications were however more amongst the first one thousand 
patients24. Focusing on the obese patients in the current study, no trend was observed in complication rates when 
grouped according to the year of surgery (Table 6). Most of these were attributed to transient hypocalcemia in 
BTT, transient voice hoarseness and seroma.
The reason why no reduction in complication rates over time was seen in our series, as would be expected 
when a surgeon becomes more experienced, is because being a training hospital, many operations were per-
formed by different trainees with varying skills and experience, especially in the later years of this study. We 
cannot assume that time (years) is related to learning curve, as we usually can if this was a single surgeon series. 
This is one of the limitations of this study. The operative time and complications were not grouped by surgeon 
experience. However, inclusion of surgeons with different levels of experience makes the data more relevant to 
surgeons who are starting RTAT in their surgical practice.
Another limitation of this study is that although the number of obese patients in our cohort was quite large 
(N = 76), they were only 2.1% of the total cohort. Our patients were also a homogenous group of Korean patients, 
with few patients from other ethnicities having this surgery at our institution. It is however worthwhile noting 
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that the distribution of obese patients across the seven years of our study was completely random (p = 0.328) 
(Figs 1 and 2), except in 2007, when no obese patients were offered this surgery during the introduction of RTAT. 
We were not operating on more obese patients as we gained more experience in the later years of the study, which 
could have influenced our results.
Finally, the TNM staging in our data was based on the 7th edition of the AJCC/TNM classification, rather 
than the 8th edition because our data was collected prior to the publication of the new edition in October 201625. 
A large number of T3 patients (43.8%) had only minor extrathyroidal tumor extension into strap muscles. If the 
patients were to be re-staged according to the 8th edition, most of these patients would be down staged to either 
T1 or T2.
Despite these limitations, this study is important to highlight that higher BMI is not related to serious thy-
roidectomy complications such as RLN injury, tracheal perforation or major vessel injury when using the RTAT 
approach.
Conclusion
Robotic transaxillary thyroidectomy is a safe procedure. Body mass index did not significantly influence the 
rates of post-operative complications or long-term outcomes, apart from transient voice hoarseness and seroma 
formation. Patients with higher BMI, however, required longer operative times, especially during flap creation. 
Therefore, a high BMI should not be a contraindication to performing robotic transaxillary thyroidectomy by an 
adequately trained surgeon.
Data Availability
The datasets generated during/and or analyzed during the current study are not publicly available due to patient 
privacy. They are available from the corresponding author on reasonable request.
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